Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7478-7487

  Björndal, Åsa ^a   Deng, Hongkui ^b   Jansson, Marianne ^a   Fiore, José R ^a,c   Colognesi, Claudia ^d   Karlsson, Anders ^e   Albert, Jan ^f   Scarlatti, Gabriella ^a,d   Littman, Dan R ^b   Fenyö, Eva Maria ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE SEVERITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; TARGET CELL; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS ISOLATION;

EID: 1842415431     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7478-7487.1997     Document Type: Article

References (49)

1. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1 α, MIP-1 β, receptor as a fusion cofactor for macrophage-tropic HIV-1 Science 272: 1955-1958.
2. Berson, J. F., D. Long, B. J. Doranz, J. Rucker, F. R. Jirik, and R. W. Doms. 1996. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J. Virol. 70: 6288-6295.
3. Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodruski, and T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-833.
4. Bleul, C. C., L. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differently expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94:1925-1930.
5. Cheng-Mayer, C., D. Seto, M. Tateno, and J. A. Levy. 1988. Biological features of HIV-1 that correlate with virulence in the host. Science 240:80-82.
6. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. MacKay, G. LaRosa, W. Newman, N. Gerard, G. Gerard, and J. Sodroski. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
7. + T cells. Science 270:1811-1815.
8. Connor, R. I., B. K. Chen, S. Choe, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-944.
9. 8a. Connor, R. I., K. E. Sheridan, D. Ceradini, S. Choe, and N. R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:621-628.
10. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
11. 9a. Deng, H., and D. R. Littman. Unpublished data.
12. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusin cofactors. Cell 85:1149-1158.
13. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CRK-5. Nature 381:667-673.
14. D'Souza, M. P., and V. A. Harden. 1996. Chemokines and HIV-1 second receptors. Nat. Med. 2:1293-1300.
15. Endres, M. J., P. R. Clapham, M. Marsh, M. Ahuja, J. D. Turner, A. McKnight, J. F. Thomas, B. Stoebenau-Haggarty, S. Choe, P. J. Vance, T. N. C. Wells, C. A. Power, S. S. Sutterwala, R. W. Doms, N. R. Landau, and J. A. Hoxie. 1996. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87:745-756.
16. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
17. Fenyö, E. M. 1996. HIV biological phenotype: prognosis marker for transmission, disease progression and therapy. J. Biol. Regul. Homeostatic Agents 9:88-90.
18. Fenyö, E. M. 1996. HIV-1 biological phenotype varies with severity of infection across HIV-1 genetic subtypes. Antibiot. Chemother. 48:49-55.
19. Fenyö, E. M., L. Morfeidt-Månson, F. Chiodi, A. Lind, A. von Gegerfelt, J. Albert, E. Olausson, and B. Åsjö. 1988. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62:4414-4419.
20. Fiore, J. R., Å. Björndal, K. Aperia-Peipke, M. Di Stefano, G. Angarano, G. Pastore, H. Gaines, E. M. Fenyö, and J. Albert. 1994. The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology 204:297-303.
21. Gao, F., S. G. Morrisson, D. L. Robertson, C. L. Thorton, S. Craig, G. Karlsson, J. Sodroski, M. Morgado, B. Galvao-Castro, H. von Briesen, S. Beddows, J. Weber, P. M. Sharp, G. M. Shaw, B. H. Hahn, and the WHO Network for HIV Isolation and Characterization. 1996. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. J. Virol. 70:1651-1667.
22. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
23. Holm-Hansen, C., D. Grothues, S. Rustad, B. Roøsok, F. R. Pascu, and B. Åsjö. 1995. Characterization of HIV-1 from Romanian children: lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells. AIDS Res. Hum. Retroviruses 11:597-604.
24. Jansson, M., M. Popovic, A. Karlsson, F. Cocchi, P. Rossi, J. Albert, and H. Wigzell. 1996. Sensitivity to inhibition by β-chemokines correlates with biological phenotype of primary HIV-1 isolates. Proc. Natl. Acad. Sci. USA 93:15382-15387.
25. Karlsson, A., K. Parsmyr, E. Sandstrom, E. M. Fenyö, and J. Albert. 1994. MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J. Clin. Microbiol. 32:364-370.
26. Koot, M., I. P. M. Keet, A. H. V. Vos, R. E. Y. de Goede, M. T. L. Roos, R.A. Coutinho, F. Miedema, P. T. A. Schellekens, and M. Tersmette. 1993. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann. Intern. Med. 118:681-688.
27. Louwagie, J., F. E. McCutchan, M. Peelers, T. P. Brennan, E. Sanders-Buell, G. A. Eddy, G. van der Groen, K. Fransen, G.-M. Gershy-Damet, R. Deleys, and D. S. Burke. 1993. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 7:769-780.
28. Marquina, S., T. Leitner, R. D. Rabinovich, J. Benetucci, O. Libonatti, and J. Albert. 1996. Coexcistence of subtypes B, F, and a B/F env recombinant of HIV type 1 in Buenos Aires, Argentina. AIDS Res. Hum. Retroviruses 12:1651-1654.
29. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
30. Mustafa, F., J. F. L. Richmond, R. Fernandez-Larsson, S. Lu, R. Fredriksson, E. M. Fenyö, M. O'Connell, E. Johnson, J. Weng, J. C. Santoro, and H. L. Robinson. 1997. HIV-1 env glycoproteins from two series of primary isolates: replication phenotype and immunogenicity. Virology 229:269-278.
31. Myers, G. 1994. HIV: between past and future. AIDS Res. Hum. Retroviruses 10:1317-1324.
32. Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J.-L. Virelizer, F. Arenzana-Seisdedos, O. Schwartz, J.-M. Heard, I. Clark-Lewis, D. F. Legier, M. Loetscher, M. Baggiolini, and B. Moser. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833-835.
33. Premack, B. A., and T. J. Schall. 1996. Chemokine receptors: gateway to inflammation and infection. Nat. Med. 2:1174-1178.
34. Rübsamen-Waigmann, H., H. von Briesen, H. Holmes, Å. Björndal, B. Korber, R. Esser, S. Ranjbar, P. Tomlinson, B. Galvao-Castro, E. Karita, S. Sempala, C. Wasi, S. Osmanov, E. M. Fenyö, and the WHO Network for HIV Isolation and Characterization. 1994. Standard conditions of virus isolation reveal biological variability of HIV-1 in different regions of the world. AIDS Res. Hum. Retroviruses 10:1401-1408.
35. Scarlatti, G., V. Hodara, C. Colognesi, A. Beretta, J. Albert, and E. M. Fenyö. 1995. Autologous neutralizing antibody response and virus phenotype in progression of disease of HIV-1 infected children. J. Cell. Biochem. Suppl. 19D:451.
36. Scarlatti, G., V. Hodara, P. Rossi, L. Muggiasca, A. Bucceri, J. Albert, and E. M. Fenyö. 1993. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother-to-child correlates with viral phenotype. Virology 197: 624-629.
37. Schuitemaker, H., M. Koot, N. A. Koostra, M. W. Dercksen, R. E. Y. De Goede, R. P. Van Steenwijk, J. M. Lange, J. K. Eeftink Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66:1354-1360.
38. 35a. Shimizu, N. S., N. G. Shimizu, Y. Takeuchi, and H. Hoshino. 1994. Isolation and characterization of human immunodeficiency virus type 1 variants infectious to brain-derived cells: detection of common point mutations in the V3 region of the env gene of the variants. J. Virol. 68:6130-6135.
39. 35b. Simmons, G., D. Wilkinson, J. D. Reeves, M. T. Dittmar, S. Beddows, J. Weber, G. Carnegie, U. Desselberger, P. W. Gray, R. A. Weiss, and P. R. Clapham. 1996. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70:8355-8360.
40. Sundqvist, V. A., J. Albert, E. Ohlsson, J. Hinkula, E. M. Fenyö, and B. Wahren. 1989. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J. Med. Virol. 29:170-175.
41. Tersmetle, M., R. E. Y. De Goede, B. J. Al, I. Winkel, B. Gruters, H. T. Cuypers, H. G. Huisman, and F. Miedema. 1988. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62:2026-2032.
42. Tersmette, M., B. A. Gruters, F. de Wolf, R. E. Y. de Goede, J. M. A. Lange, P. T. A. Schellekens, J. Goudsmit, H. G. Huisman, and F. Miedema. 1989. Evidence for a role of virulent human immunodeficiency virus (HIV) varitants in the pathogencsis of acquired immunodeficiency syndrome: studies on sequential isolates. J. Virol. 63:2118-2125.
43. von Gegerfelt, A., J. Albert, L. Morfeldt-Månson, K. Broliden, and E. M. Fenyö. 1991. Isolate-specific neutralizing antibodies in patients with progressive HIV-1 related disease. Virology 185:162-168.
44. Weber, J., E. M. Fenyö, S. Bebbows, P. Kaleebu, Å. Björndal, and the WHO Network for HIV Isolation and Characterization. 1996. Neutralization serotypes of HIV-1 field isolates are not predicted by genetic subtype. J. Virol. 70:7827-7832.
45. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.
46. Westermark, B., J. Ponten, and R. Hugosson. 1973. Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol. Microbiol. Scand. 81:791-805.
47. WHO Network for HIV Isolation and Characterization. 1994. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res. Hum. Retroviruses 10:1327-1344.
48. Zhang, L., Y. Huang, T. He, Y. Cao, and D. D. Ho. 1996. HIV-1 subtype and second-receptor use. Nature 383:768.
49. Åsjö, B., L. Morfeldt-Månson, J. Albert, G. Biberfeld, A. Karlsson, K. Lidman, and E. M. Fenyö. 1986. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet ii:660-662.